- LB-100
-
- $1.00 / 1KG
-
2019-07-06
- CAS:1026680-07-8
- Min. Order: 1KG
- Purity: 98-100%
- Supply Ability: 1000kg
|
| Product Name: | LB-100 | | Synonyms: | 3-(4-METHYLPIPERAZINE-1-CARBONYL)-7-OXABICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID;LB-100;3-(1-methylpiperazine-4-carbonyl)-7-oxa-bicyclo[2.2.1]heptane-2-carboxylic acid;LB-100 3-(4-METHYLPIPERAZINE-1-CARBONYL)-7-OXABICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID;methyl 2,5-dimethyl-1-[(2-methylpropan-2-yl)oxycarbonylamino]pyrrole-3-carboxylate LB-100;LB-100, 1026680-07-8;LB-100, >95%;CS-1762 | | CAS: | 1026680-07-8 | | MF: | C13H20N2O4 | | MW: | 268.3089 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 1026680-07-8.mol |  |
| | LB-100 Chemical Properties |
| Melting point | >214°C (dec.) | | storage temp. | Amber Vial, -20°C Freezer, Under inert atmosphere | | solubility | DMSO (Very Slightly, Heated), Methanol (Very Slightly, Heated) | | form | Solid | | color | White |
| | LB-100 Usage And Synthesis |
| Uses | LB-100 is a small molecule inhibitor of protein phosphatase 2A with potent chemo- and radio-sensitizing potential in variety of cancer types including pancreatic cancer and colorectal cancer of human and animal model. | | Biological Activity | lb-100 is an inhibitor of protein phosphatase 2a (pp2a) with anticancer activity, with ic50 of 0.85 μm and 3.87 μm in bxpc-3 and panc-1 cells, respectively[1].in bxpc-3, panc-1, and sw1990 cells, lb-100 treatment reduced pp2a activity by 30-50%. lb-100 increases the intracellular doxorubicin concentration (about 2.5 times that of the control group) and makes tumor cells more sensitive to the cytotoxicity of doxorubicin[1].in a panc-1 mouse xenograft model, lb-100 (2 mg / kg, intraperitoneal injection) improves the efficacy of the chemotherapy drug doxorubicin. lb-100 increases tumor microvessel density and blood flow velocity on the tumor surface, and decreases tumor volume[1].[1]. bai x, zhi x, zhang q, et al. inhibition of protein phosphatase 2a sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via hif-1α-vegf mediated angiogenesis. cancer lett, 2014, 355(2): 281-287. |
| | LB-100 Preparation Products And Raw materials |
|